Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...
Current drugs for pancreatic cancer lose effectiveness within months because the tumor becomes resistant. Now, a group from Spain's National Cancer Research Centre (CNIO) has been able to avoid the ...
Pancreatic cancer is one of the most aggressive tumours with the worst prognosis, partly because of the rapid emergence of resistance to treatment. But a new study from the Spanish National Cancer ...
A Spanish research team says it has developed a treatment that completely eliminated the most aggressive form of pancreatic cancer in laboratory mice, raising fresh hopes against one of the deadliest ...
What Is Pancreatitis in Cats? Pancreatitis happens when your cat’s pancreas becomes inflamed. It can be sudden and short-term, known as acute pancreatitis, or ongoing, called chronic pancreatitis. The ...
Agency updates guidance after increase in reports of condition to its yellow card scheme Patients on weight-loss jabs and diabetes injections should be aware there is a small risk of developing severe ...
The UK warned some patients have died of severe inflammation of the pancreas linked to obesity and diabetes drugs such as Eli Lilly & Co.’s Mounjaro and Novo Nordisk A/S’s Wegovy. Though the worst ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has updated the product information for GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists to reflect a small risk of severe ...
People using GLP-1 injections like Wegovy to lose weight should be aware of the rare but real chance of developing severe inflammation of the pancreas, known as acute pancreatitis, external. The ...
The quad axel is the most difficult skill ever performed in figure skating – and the only person in the world who has ever landed one in competition is Ilia Malinin. If you haven't heard his name ...
Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. The UK’s medicines regulator has warned that patients using weight-loss drugs known as GLP-1s face a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results